ProteoMediX enables personalized medicine by developing non-invasive diagnostic tests to detect and assess the prognosis of cancer, as well as to match patients with safer and more effective therapies.

Location
Facts & figures
  • Type of organization
    Private company
  • Year of foundation
    2010
  • Number of employees in Switzerland
    10-19
Core competencies